U.S. chemical companies say the demand for dry ice — solid carbon dioxide — is soaring ahead of the rollout of the Pfizer-BioNTech COVID-19 vaccine, which needs to be kept below –70 C for storage and transport.
U.S. chemical companies say the demand for dry ice — solid carbon dioxide — is soaring ahead of the rollout of the Pfizer-BioNTech COVID-19 vaccine, which needs to be kept below –70 C for storage and transport.